Last update 21 Nov 2024
Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Last update 21 Nov 2024
Overview
Basic Info
Drug Type Mesenchymal stem cell therapy |
Synonyms allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) |
Target- |
Mechanism Stem cell replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)Clinical Trial Phase IIa to Evaluate the Safety and Effectiveness of Treatment With Fat-derived Mesenchymal Allogenic Mesenchymal Troncal Cells in Patients With Single Inflammatory Stenosis in the Context of Crohn's Disease.
Assessment of Efficacy and Safety of the allogeneic adipose derived mesenchymal stem cells along with platelet rich fibrin in 24 patients with perianal fistulas: a phase 1 and 2 pilot randomized, single blinded trial
100 Clinical Results associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Login to view more data
100 Translational Medicine associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Login to view more data
100 Patents (Medical) associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Login to view more data
100 Deals associated with Allogeneic adipose-derived mesenchymal stem cells(Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Constriction, Pathologic | Phase 2 | ES | 24 Oct 2022 | |
| Crohn Disease | Phase 2 | ES | 24 Oct 2022 | |
| Conjunctivitis, Inclusion | Phase 2 | ES | 01 Sep 2022 | |
| Stevens-Johnson Syndrome | Phase 2 | ES | 01 Sep 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free